-
s Incidence and Risk Factors of Venous and Arterial Thromboembolism in Immune Checkpoint Inhibitor Therapy
- Source: Current Pharmaceutical Design, Volume 28, Issue 36, Oct 2022, p. 2950 - 2952
-
- 01 Oct 2022
Preview this article:




Incidence and Risk Factors of Venous and Arterial Thromboembolism in Immune Checkpoint Inhibitor Therapy, Page 1 of 1
< Previous page Next page > /docserver/preview/fulltext/cpd/28/36/s2-1.gif
There is no abstract available.
© Bentham Science Publishers